Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-09-13

FDA Approved: NADOLOL — Original Application (VGYAAN Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved Nadolol as a generic product through an Original Application (ANDA) from VGYAAN Pharmaceuticals LLC. Nadolol is a non-selective beta-blocker us…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nadolol (Nadolol)

Snippet

ORIG AP for NADOLOL (NADOLOL)